Top

Osteoporosis International

Published in:

01-07-2009 | Original Article

Bone turnover markers are correlated with quantitative ultrasound of the calcaneus: 5-year longitudinal data

Authors: J. Lenora, P. Gerdhem, K. J. Obrant, K. K. Ivaska

Published in: Osteoporosis International | Issue 7/2009

Abstract

Summary

Associations between bone turnover markers and calcaneal ultrasound (quantitative ultrasound, QUS) were studied in a population-based sample of 810 elderly women. Baseline bone turnover markers correlated with baseline QUS as well as with 5-year prospective changes in QUS.

Introduction

Bone turnover markers are associated with areal bone mineral density, but the knowledge on the association with QUS is limited.

Methods

Eight hundred ten women, all 75 years old, were investigated at baseline. Five hundred six completed a 5-year follow-up. Bone turnover markers and calcaneal QUS [speed of sound (SoS), broadband ultrasound attenuation (BUA), stiffness] were investigated at baseline. QUS was investigated at follow-up.

Results

All bone turnover markers were correlated with baseline QUS [standardized regression (Beta_std) values from −0.07, p < 0.05 to −0.23, p < 0.001], with the exception of bone-specific alkaline phosphatase (S-Bone ALP) which was not correlated with BUA and stiffness index. When the correlations between baseline bone turnover markers and 5-year changes in QUS were analyzed, three serum osteocalcins were correlated with changes of SoS and stiffness index (Beta_std = −0.11, p < 0.05 to −0.17, p < 0.001). Also S-CTX-I correlated with changes of SoS and stiffness index (Beta_std = −0.10 and −0.09, respectively, p < 0.05). S-TRACP5b, urinary deoxypyridinoline/crea, and U-MidOC/crea correlated with changes of SoS (Beta_std = −0.10 and p < 0.05 for all). S-Bone ALP did not correlate with change of QUS. None of the bone turnover markers correlated with changes of BUA.

Conclusions

Bone turnover markers correlate with concomitantly assessed QUS as well as with longitudinal change in QUS.

Glüer CC (2007) Quantitative ultrasound—it is time to focus research efforts. Bone 40:9–13PubMedCrossRef

WHO Study Group (1994) Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group. WHO Tech Rep Ser 843:1–129

Njeh CF, Boivin CM, Langton CM (1997) The role of ultrasound in the assessment of osteoporosis: a review. Osteoporos Int 7:7–22PubMedCrossRef

Siffert RS, Kaufman JJ (2007) Ultrasonic bone assessment: “the time has come”. Bone 40:5–8PubMedCrossRef

Hans D, Arlot ME, Schott AM et al (1995) Do ultrasound measurements on the os calcis reflect more the bone microarchitecture than the bone mass?: a two-dimensional histomorphometric study. Bone 16:295–300PubMedCrossRef

Njeh CF, Fuerst T, Diessel E et al (2001) Is quantitative ultrasound dependent on bone structure? A reflection. Osteoporos Int 12:1–15PubMed

Stewart A, Kumar V, Reid DM (2006) Long-term fracture prediction by DXA and QUS: a 10-year prospective study. J Bone Miner Res 21:413–418PubMedCrossRef

Huopio J, Kroger H, Honkanen R et al (2004) Calcaneal ultrasound predicts early postmenopausal fractures as well as axial BMD. A prospective study of 422 women. Osteoporos Int 15:190–195PubMedCrossRef

Gerdhem P, Ivaska KK, Alatalo SL et al (2004) Biochemical markers of bone metabolism and prediction of fracture in elderly women. J Bone Miner Res 19:386–393PubMedCrossRef

10.

Garnero P, Hausherr E, Chapuy MC et al (1996) Markers of bone resorption predict hip fracture in elderly women: the EPIDOS Prospective Study. J Bone Miner Res 11:1531–1538PubMedCrossRef

11.

Garnero P, Sornay-Rendu E, Claustrat B et al (2000) Biochemical markers of bone turnover, endogenous hormones and the risk of fractures in postmenopausal women: the OFELY Study. J Bone Miner Res 15:1526–1536PubMedCrossRef

12.

Luukinen H, Käkönen SM, Pettersson K et al (2000) Strong prediction of fractures among older adults by the ratio of carboxylated to total serum osteocalcin. J Bone Miner Res 15:2473–2478PubMedCrossRef

13.

Lenora J, Ivaska KK, Obrant KJ et al (2007) Prediction of bone loss using biochemical markers of bone turnover. Osteoporos Int 18:1297–1305PubMedCrossRef

14.

Rogers A, Hannon RA, Eastell R (2000) Biochemical markers as predictors of rates of bone loss after menopause. J Bone Miner Res 15:1398–1404PubMedCrossRef

15.

Dresner-Pollak R, Parker RA, Poku M et al (1996) Biochemical markers of bone turnover reflect femoral bone loss in elderly women. Calcif Tissue Int 59:328–333PubMedCrossRef

16.

Löfman O, Magnusson P, Toss G et al (2005) Common biochemical markers of bone turnover predict future bone loss: a 5-year follow-up study. Clin Chim Acta 356:67–75PubMedCrossRef

17.

Chapurlat RD, Gamero P, Sornay-Rendu E et al (2000) Longitudinal study of bone loss in pre- and perimenopausal women: evidence for bone loss in perimenopausal women. Osteoporos Int 11:493–498PubMedCrossRef

18.

Bauer DC, Sklarin PM, Stone KL et al (1999) Biochemical markers of bone turnover and prediction of hip bone loss in older women: the study of osteoporotic fractures. J Bone Miner Res 14:1404–1410PubMedCrossRef

19.

Garnero P, Sornay-Rendu E, Duboeuf F et al (1999) Markers of bone turnover predict postmenopausal forearm bone loss over 4 years: the OFELY study. J Bone Miner Res 14:1614–1621PubMedCrossRef

20.

Hoshino H, Kushida K, Takahashi M et al (2000) Changes in levels of biochemical markers and ultrasound indices of os calcis across the menopausal transition. Osteoporos Int 11:128–133PubMedCrossRef

21.

Lappa V, Dontas IA, Trovas G et al (2007) Quantitative ultrasound is better correlated with bone mineral density and biochemical bone markers in elderly women. Clin Rheumatol 26:1067–1073PubMedCrossRef

22.

Cortet B, Cortet C, Blanckaert F et al (2000) Bone ultrasonometry and turnover markers in primary hyperparathyroidism. Calcif Tissue Int 66:11–15PubMedCrossRef

23.

Veitch SW, Findlay SC, Hamer AJ et al (2006) Changes in bone mass and bone turnover following tibial shaft fracture. Osteoporos Int 17:364–372PubMedCrossRef

24.

Karlsson MK, Obrant KJ, Nilsson BE et al (1998) Bone mineral density assessed by quantitative ultrasound and dual energy X-ray absorptiometry. Normative data in Malmo, Sweden. Acta Orthop Scand 69:189–193PubMedCrossRef

25.

Käkönen SM, Hellman J, Karp M et al (2000) Development and evaluation of three immunofluorometric assays that measure different forms of osteocalcin in serum. Clin Chem 46:332–337PubMed

26.

Halleen JM, Alatalo SL, Suominen H et al (2000) Tartrate-resistant acid phosphatase 5b: a novel serum marker of bone resorption. J Bone Miner Res 15:1337–1345PubMedCrossRef

27.

Ivaska KK, Käkönen SM, Gerdhem P et al (2005) Urinary osteocalcin as a marker of bone metabolism. Clin Chem 51:618–628PubMedCrossRef

28.

Ivaska KK, Lenora J, Gerdhem P et al (2008) Serial assessment of serum bone metabolism markers identifies women with the highest rate of bone loss and osteoporosis risk. J Clin Endocrinol Metab 93:2622–2632PubMedCrossRef

29.

Glüer CC (1997) Quantitative ultrasound techniques for the assessment of osteoporosis: expert agreement on current status. The International Quantitative Ultrasound Consensus Group. J Bone Miner Res 12:1280–1288PubMedCrossRef

30.

Barkmann R, Laugier P, Moser U et al (2007) A method for the estimation of femoral bone mineral density from variables of ultrasound transmission through the human femur. Bone 40:37–44PubMedCrossRef

31.

Hans D, Fuerst T, Duboeuf F (1997) Quantitative ultrasound bone measurement. Eur Radiol 7:43–50PubMedCrossRef

32.

Gerdhem P, Magnusson H, Karlsson MK et al (2002) Ultrasound of the phalanges is not related to a previous fracture. A comparison between ultrasound of the phalanges, calcaneus, and DXA of the spine and hip in 75-year-old women. J Clin Densitom 5:159–166PubMedCrossRef

33.

Marcus R, Holloway L, Wells B et al (1999) The relationship of biochemical markers of bone turnover to bone density changes in postmenopausal women: results from the Postmenopausal Estrogen/Progestin Interventions (PEPI) trial. J Bone Miner Res 14:1583–1595PubMedCrossRef

34.

Sarkar S, Reginster JY, Crans GG et al (2004) Relationship between changes in biochemical markers of bone turnover and BMD to predict vertebral fracture risk. J Bone Miner Res 19:394–401PubMedCrossRef

35.

Melton LJ 3rd, Atkinson EJ, O’Connor MK et al (2000) Determinants of bone loss from the femoral neck in women of different ages. J Bone Miner Res 15:24–31PubMedCrossRef

36.

Stepan JJ, Havrdova E, Tyblova M et al (2004) Markers of bone remodeling predict rate of bone loss in multiple sclerosis patients treated with low dose glucocorticoids. Clin Chim Acta 348:147–154PubMedCrossRef

37.

Dennison E, Eastell R, Fall CH et al (1999) Determinants of bone loss in elderly men and women: a prospective population-based study. Osteoporos Int 10:384–391PubMedCrossRef

38.

Halleen JM, Ranta R (2001) Tartrate-resistant acid phosphatase as a serum marker of bone resorption. Am Clin Lab 20:29–30PubMed

39.

Janckila AJ, Takahashi K, Sun SZ et al (2001) Tartrate-resistant acid phosphatase isoform 5b as serum marker for osteoclastic activity. Clin Chem 47:74–80PubMed

40.

Iki M, Morita A, Ikeda Y et al (2006) Biochemical markers of bone turnover predict bone loss in perimenopausal women but not in postmenopausal women—the Japanese Population-Based Osteoporosis (JPOS) Cohort Study. Osteoporos Int 17:1086–1095PubMedCrossRef

41.

Bruyere O, Collette J, Delmas P et al (2003) Interest of biochemical markers of bone turnover for long-term prediction of new vertebral fracture in postmenopausal osteoporotic women. Maturitas 44:259–265PubMedCrossRef

42.

Delmas PD, Eastell R, Garnero P et al (2000) The use of biochemical markers of bone turnover in osteoporosis. Committee of Scientific Advisors of the International Osteoporosis Foundation. Osteoporos Int 11(Suppl 6):S2–17PubMedCrossRef

43.

Cosman F, Nieves J, Wilkinson C et al (1996) Bone density change and biochemical indices of skeletal turnover. Calcif Tissue Int 58:236–243PubMed

44.

Krieg MA, Barkmann R, Gonnelli S et al (2008) Quantitative ultrasound in the management of osteoporosis: the 2007 ISCD Official Positions. J Clin Densitom 11:163–187PubMedCrossRef

Title: Bone turnover markers are correlated with quantitative ultrasound of the calcaneus: 5-year longitudinal data
Authors: J. Lenora
P. Gerdhem
K. J. Obrant
K. K. Ivaska
Publication date: 01-07-2009
Publisher: Springer-Verlag
Published in: Osteoporosis International / Issue 7/2009
Print ISSN: 0937-941X
Electronic ISSN: 1433-2965
DOI: https://doi.org/10.1007/s00198-008-0769-x

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Bone turnover markers are correlated with quantitative ultrasound of the calcaneus: 5-year longitudinal data

Abstract

Summary

Introduction

Methods

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Summary

Introduction

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 7/2009

Monitoring strontium ranelate therapy in patients with osteoporosis

Age, gender, and race/ethnic differences in total body and subregional bone density

Relation between fibroblast growth factor-23, body weight and bone mineral density in elderly men

Preventative effect of exercise against falls in the elderly: a randomized controlled trial

A case of familial tumoral calcinosis/hyperostosis–hyperphosphatemia syndrome due to a compound heterozygous mutation in GALNT3 demonstrating new phenotypic features

Vitamin D insufficiency does not affect response of bone mineral density to alendronate